Blood cancers, Myelodysplastic syndrome (MDS)
Results
Phase 1
This trial looked at combining eltrombopag with azacitidine for people with myelodysplastic syndrome (MDS).
This trial was open for people to join between 2014 and 2018. The team reported the results in 2021.
Recruitment start: 15 October 2014
Recruitment end: 30 August 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Alex Sternberg
Blood Cancer UK
Celgene
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
University of Birmingham
Last reviewed: 20 July 2022
CRUK internal database number: 10475
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
